DEPUY SYNTHES COMPANY
Johnson & Johnson explores $20 billion sale of orthopedics unit, source saysJohnson & Johnson is planning to sell its orthopedics unit, DePuy Synthes. The deal could be worth more than twenty billion dollars. Privat...
Johnson & Johnson stock falls after company lays out plan to spin off orthopaedics businessJohnson & Johnson is planning to separate its orthopedics business into a new company called DePuy Synthes. This will let J&J focus on medi...
Alkem Labs diversifies into medical devices bizAlkem Laboratories has become the first Indian drugmaker to diversify into medical devices after partnering with US-based Exactech to manuf...
- Load More